ETFs Holding ACRX »    ACRX Historical Stock Prices »
ACRX News Video: Tue, Aug 1, 2017, 1:44 PM — Tuesday Sector Laggards: Trucking, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AcelRx Pharmaceuticals is a pharmaceutical company. Co.'s product candidates, focused on the treatment of acute pain are, DSUVIA™ (known as DZUVEO outside of the U.S.), and ZALVISO®, each of which utilizes sublingual sufentanil, delivered via a non-invasive route of sublingual administration, for use in medically supervised settings. DSUVIA is a non-invasive investigational product candidate consisting of sufentanil tablets delivered sublingually by a healthcare personnel using a disposable, pre-filled, single-dose applicator. ZALVISO consists of sufentanil sublingual tablets delivered by the ZALVISO System, a needle-free, handheld, patient-administered, pain management system. Self directed investors in AcelRx Pharmaceuticals Inc will be interested in keeping up with all AcelRx Pharmaceuticals Inc news they can find, both ACRX news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ACRX. At RediNews, we simplify this task by presenting both ACRX news releases originating from AcelRx Pharmaceuticals Inc itself, and ACRX news from a variety of media outlets. Visitors can browse this news online and through our ACRX RSS news feed.


ACRX News — Articles, Videos, & Press Releases

Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I
Thursday, June 13, 2019, 3:05 PM — Zacks
First Week of July 19th Options Trading For AcelRx Pharmaceuticals (ACRX)
Tuesday, May 21, 2019, 10:54 AM — Stock Options Channel
Add Up The Parts: BIB Could Be Worth $61
Tuesday, May 21, 2019, 7:55 AM — ETF Channel
First Week of December 20th Options Trading For AcelRx Pharmaceuticals (ACRX)
Monday, April 29, 2019, 11:12 AM — Stock Options Channel
Top Buys by Directors: Edwards's $115.3K Bet on ACRX
Friday, April 5, 2019, 3:04 PM — Dividend Channel
Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy
Wednesday, April 3, 2019, 7:16 AM — Zacks
Surprising Analyst 12-Month Target For IBB
Thursday, March 14, 2019, 7:25 AM — ETF Channel
First Week of September 20th Options Trading For AcelRx Pharmaceuticals (ACRX)
Friday, January 25, 2019, 10:51 AM — Stock Options Channel
Implied SPTM Analyst Target Price: $38
Monday, January 21, 2019, 8:39 AM — ETF Channel
Interesting ACRX Put Options For February 15th
Friday, January 4, 2019, 10:44 AM — Stock Options Channel
Surprising Analyst 12-Month Target For SPSM
Thursday, December 20, 2018, 7:58 AM — ETF Channel
First Week of June 2019 Options Trading For AcelRx Pharmaceuticals (ACRX)
Thursday, October 25, 2018, 10:54 AM — Stock Options Channel
Surprising Analyst 12-Month Target For SPTM
Monday, October 22, 2018, 7:45 AM — ETF Channel
Insiders Seeing Green With ACRX At New 52-Week High
Monday, October 15, 2018, 1:11 PM — Market News Video
Top Buys by Top Brass: Chief Medical Officer Palmer's $101.8K Bet on ACRX
Wednesday, September 5, 2018, 12:02 PM — Dividend Channel
Bargain Hunters Take Note: Insider Cluster-Buying At ACRX
Tuesday, August 28, 2018, 1:57 PM — Dividend Channel
ACRX is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

SSH News
Q News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ACRX News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.